Walmart will offer its employees free GLP-1 drugs and more than 250 other medications at no cost, expanding health benefits for one of the largest U.S. private-sector workforces. The retailer confirmed the move in a report published by Fox Business.

The decision puts Walmart among the employers directly absorbing the cost of GLP-1 medications — the weight-loss and diabetes drug class that has become one of the fastest-growing line items in employer health plans. For HR and benefits leaders, it signals that full coverage of these drugs, without employee cost-sharing, has moved from pilot experiment to practice at a Fortune 1 scale.

Walmart employs roughly 1.6 million people in the U.S., and the nation's largest private employer has faced sustained pressure on wages, retention and healthcare affordability across its stores and supply chain. The company has positioned expanded health benefits as part of that retention strategy.

What does the change cover?

The expansion centers on two components:

• Free GLP-1 medications for employees enrolled in the company's health coverage
• More than 250 prescription drugs offered at no cost to workers

The list of covered medications spans common chronic-condition treatments, per Fox Business's reporting. The move effectively eliminates copays for a broad slice of the pharmacy benefit.

Why does this matter for benefits leaders?

GLP-1 drugs such as those used for diabetes and weight management can list at roughly $1,000 per month per patient before rebates, which is why many employers have capped coverage, added prior authorization or shifted costs to employees. Walmart's decision to cover them free runs against that caution.

The retailer has an obvious structural advantage: it operates one of the largest pharmacy businesses in the country. That scale shapes the economics of the benefit in ways most employers can't replicate, and analysts will watch whether other large self-insured employers follow or whether Walmart's move stays an outlier tied to its pharmacy footprint.

For people-operations teams, the practical questions are the familiar ones any GLP-1 coverage decision raises: eligibility criteria, duration limits, wraparound programs such as nutrition and exercise support, and how utilization data feeds next year's plan design.

What's the retention angle?

Health benefits have become a competitive lever in hourly-wage industries where turnover is high and healthcare access is uneven. Free medications reduce a direct, recurring cost for workers, and Walmart has previously framed benefit expansions as retention and recruitment tools rather than pure compensation costs.

Employers competing for the same frontline labor pool — grocery, logistics, warehouse and retail — will likely benchmark the announcement against their own pharmacy benefits during coming plan-year negotiations.

Walmart hasn't detailed the full rollout timing or eligibility rules in the initial announcement, so HR teams watching the move should watch for the plan documents. If the largest U.S. employer can absorb GLP-1 costs at scale, it will raise employee expectations about what standard employer coverage should include — and put pressure on benefits design everywhere from big-box retail to corporate campuses.